Skip to main content

1 Result(s)

within Cancer Research Remove this filter J. Wadsley Remove this filter

and

  1. Article

    Open Access

    Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma

    Nab-paclitaxel plus gemcitabine (nabP+gemcitabine) offers modest survival gains for patients with metastatic pancreatic ductal adenocarcinoma (PDAC). Sequential scheduling of nabP+gemcitabine in a PDAC mouse m...

    P. G. Corrie, W. Qian, B. Basu, J. W. Valle, S. Falk, C. lwuji… in British Journal of Cancer (2020)

    Download PDF (936 KB) View Article